Literature DB >> 27629667

Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.

Mazen Jazi1, George Porfiris2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27629667      PMCID： PMC5023342     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Too much of a good thing: management of diabetic ketoacidosis in adults.

Authors:  Danielle Blouin
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 2.  SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment.

Authors:  André J Scheen
Journal:  Expert Opin Drug Saf       Date:  2015-10-29       Impact factor: 4.250

3.  Diabetic ketoacidosis: evaluation and treatment.

Authors:  Dyanne P Westerberg
Journal:  Am Fam Physician       Date:  2013-03-01       Impact factor: 3.292

Review 4.  SGLT2 Inhibitors May Predispose to Ketoacidosis.

Authors:  Simeon I Taylor; Jenny E Blau; Kristina I Rother
Journal:  J Clin Endocrinol Metab       Date:  2015-06-18       Impact factor: 5.958

5.  SGLT-2 inhibition and glucagon: Cause for alarm?

Authors:  Richard G Kibbey
Journal:  Trends Endocrinol Metab       Date:  2015-06-06       Impact factor: 12.015

6.  Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.

Authors:  Anne L Peters; Elizabeth O Buschur; John B Buse; Pejman Cohan; Jamie C Diner; Irl B Hirsch
Journal:  Diabetes Care       Date:  2015-06-15       Impact factor: 19.112

7.  Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis.

Authors:  Sanjay Kalra; Rakesh Sahay; Yashdeep Gupta
Journal:  Indian J Endocrinol Metab       Date:  2015 Jul-Aug

8.  Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.

Authors:  Tomohide Hayami; Yoshiro Kato; Hideki Kamiya; Masaki Kondo; Ena Naito; Yukako Sugiura; Chika Kojima; Sami Sato; Yuichiro Yamada; Rina Kasagi; Toshihito Ando; Saeko Noda; Hiromi Nakai; Eriko Takada; Emi Asano; Mikio Motegi; Atsuko Watarai; Koichi Kato; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2015-02-20       Impact factor: 4.232
  8 in total
  5 in total

1.  Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and "Sweet Pee Encephalopathy" in Perioperative Hospital Management.

Authors:  Christopher Mackintosh; Arti Tewari; Jason Siegel; R Doris Wang; William Freeman
Journal:  Neurohospitalist       Date:  2019-03-07

2.  Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis.

Authors:  Siddhartha Dutta; Tarun Kumar; Surjit Singh; Sneha Ambwani; Jaykaran Charan; Shoban B Varthya
Journal:  J Family Med Prim Care       Date:  2022-03-10

3.  Sodium-glucose Cotransporter-2 Induced Diabetic Ketoacidosis with Minimal Hyperglycemia.

Authors:  D Taylor Gammons; Francis L Counselman
Journal:  Clin Pract Cases Emerg Med       Date:  2018-01-11

4.  Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report.

Authors:  Ghada Elshimy; Ricardo Correa
Journal:  Cureus       Date:  2019-08-21

5.  Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.

Authors:  Pablo Lucero; Sebastián Chapela
Journal:  Case Rep Crit Care       Date:  2018-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.